IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q1 2021 Holdings

Filed 2021-05-17 | 17 holdings | $289.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte(PCVX)Common92243G108$82.1K4,168,71828.4%
Phathom(PHAT)Common71722W107$45.1K1,203,13515.6%
Spruce BioCommonE5209E109$29.7K1,792,51810.3%
Adicet(TORCEUR)Common007002108$21.0K1,615,3857.2%
Verona(VRNA)SPONDS ADR925050106$20.3K2,457,4997.0%
SientraCommon82621J105$17.4K2,390,8436.0%
NucanaADS67022C106$16.6K3,333,3335.7%
Exicure(XCUR)Common30205M101$15.1K6,977,0005.2%
Sierra OncologyCommon82640U107$14.7K871,1255.1%
SolenoCommon834203200$13.0K10,302,6024.5%
ParatekCommon699374302$7.3K1,041,1312.5%
Molecular TemplatesCommon608550109$2.5K200,0000.9%
X4 Pharma(ASNSUSD)Common98420X103$2.0K229,8850.7%
Aeglea(AGLEUSD)Common00773J103$1.9K240,5000.7%
Cymabay(CBAYUSD)Common23257D103$595131,0360.2%
ObsevaCommonH5861P103$28687,9990.1%
OcugenCommon43358V109$487,1110.0%